Alyeska Investment Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-662,405
| Closed | -$49M | – | 554 |
|
|
2024
Q4 | $49M | Buy |
+662,405
| New | +$49M | 0.18% | 143 |
|
|
2020
Q4 | – | Sell |
-15,236
| Closed | -$1.22M | – | 531 |
|
|
2020
Q3 | $1.22M | Buy |
+15,236
| New | +$1.22M | 0.02% | 375 |
|
|
2020
Q2 | – | Sell |
-270,174
| Closed | -$17M | – | 487 |
|
|
2020
Q1 | $17M | Buy |
+270,174
| New | +$17M | 0.34% | 96 |
|
|
2018
Q2 | – | Sell |
-563,007
| Closed | -$26.2M | – | 437 |
|
|
2018
Q1 | $26.2M | Buy |
+563,007
| New | +$26.2M | 0.22% | 129 |
|
|
2017
Q3 | – | Sell |
-789,780
| Closed | -$31.1M | – | 450 |
|
|
2017
Q2 | $31.1M | Sell |
789,780
-570,627
| -42% | -$22.5M | 0.26% | 127 |
|
|
2017
Q1 | $42.7M | Buy |
+1,360,407
| New | +$42.7M | 0.35% | 99 |
|
|
2015
Q3 | – | Sell |
-31,410
| Closed | -$746K | – | 473 |
|
|
2015
Q2 | $746K | Buy |
+31,410
| New | +$746K | 0.01% | 406 |
|